Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 6 | $1.34 | $1.38 | $1.35 |
| Q2 2026 | 5 | $1.62 | $1.69 | $1.66 |
| Q3 2026 | 1 | $1.67 | $1.70 | $1.68 |
| Q4 2026 | 1 | $1.77 | $1.81 | $1.79 |
| Q1 2027 | 1 | $1.58 | $1.61 | $1.59 |
| Q2 2027 | 1 | $1.80 | $1.84 | $1.82 |
| Q3 2027 | 1 | $1.83 | $1.87 | $1.85 |
| Q4 2027 | 1 | $1.91 | $1.95 | $1.93 |
| Q1 2028 | 2 | $1.67 | $1.70 | $1.69 |
| Q2 2028 | 2 | $1.93 | $1.97 | $1.95 |
| Q3 2028 | 2 | $1.95 | $1.99 | $1.97 |
| Q4 2028 | 2 | $2.03 | $2.07 | $2.05 |
Solventum Corp last posted its earnings results on Tuesday, May 5th, 2026. The company reported $1.48 earnings per share for the quarter, topping analysts' consensus estimates of $1.35 by $0.13. The company had revenue of 2.01 B for the quarter and had revenue of 8.33 B for the year. Solventum Corp has generated $9 earnings per share over the last year ($8.88 diluted earnings per share) and currently has a price-to-earnings ratio of 8.47. Solventum Corp has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/05/2026 | Q1 2026 | $1.35 | $0.07 | -1.28 | $1.97 B | $2.01 B |
| 02/27/2026 | Q4 2025 | N/A | $0.36 | N/A | $1.96 B | $2.00 B |
| 11/06/2025 | Q3 2025 | $1.43 | $7.26 | 5.83 | $2.06 B | $2.10 B |
| 08/07/2025 | Q2 2025 | N/A | $0.52 | N/A | $2.12 B | $2.16 B |
| 05/09/2025 | Q1 2025 | N/A | $0.79 | N/A | $2.02 B | $2.07 B |
| 02/28/2025 | Q4 2024 | N/A | $0.18 | N/A | $2.05 B | $2.08 B |
| 11/08/2024 | Q3 2024 | N/A | $0.70 | N/A | $2.06 B | $2.08 B |
| 08/09/2024 | Q2 2024 | N/A | $0.51 | N/A | $2.05 B | $2.08 B |
| 05/10/2024 | Q1 2024 | N/A | $1.37 | N/A | $1.97 B | $2.02 B |
| 12/30/2023 | Q4 2023 | N/A | $1.57 | N/A | N/A | $2.04 B |
| 09/29/2023 | Q3 2023 | N/A | $2.66 | N/A | N/A | $2.07 B |
| 06/29/2023 | Q2 2023 | N/A | $1.86 | N/A | N/A | $2.08 B |
| 03/30/2023 | Q1 2023 | N/A | $1.70 | N/A | N/A | $2.01 B |
| 12/30/2022 | Q4 2022 | N/A | $1.78 | N/A | N/A | $1.97 B |
| 09/29/2022 | Q3 2022 | N/A | $1.94 | N/A | N/A | $2.01 B |
| 06/29/2022 | Q2 2022 | N/A | $2.03 | N/A | N/A | $2.06 B |
| 03/30/2022 | Q1 2022 | N/A | $2.03 | N/A | N/A | $2.06 B |
In the previous quarter, Solventum Corp (:SOLV) reported $1.48 earnings per share (EPS) to beat the analysts' consensus estimate of $1.35 by $0.13.
The conference call for Solventum Corp's latest earnings report can be listened to online.
The conference call transcript for Solventum Corp's latest earnings report can be read online.
Solventum Corp (:SOLV) has a recorded annual revenue of $8.33 B.
Solventum Corp (:SOLV) has a recorded net income of $1.56 B.Solventum Corp has generated $8.94 earnings per share over the last four quarters.
Solventum Corp (:SOLV) has a price-to-earnings ratio of 8.47 and price/earnings-to-growth ratio is 0.03.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED